Targeted Investigational Treatment Analysis of Novel Anti‐androgen (TITAN) study: ultralow prostate‐specific antigen decline with apalutamide plus androgen‐deprivation therapy

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

BJU International

Topics

Medicine

Cancer Oncology

Pathology

Internal Medicine

Urology

Show all topics

DOI

10.1111/bju.16449

License

CC-BY-NC

Other Formats

PDF